Reporting Manager
RA Capital Management, L.P.
Symbol
TYRA
Shares outstanding
57,861,203 shares
Disclosed Ownership
12,266,575 shares
Ownership
21%
Form type
SCHEDULE 13D/A
Filing time
06 Mar 2026, 16:28:06 UTC
Date of event
04 Mar 2026
Previous filing
06 Jun 2025

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 21% ownership in TYRA BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (TYRA) on 04 Mar 2026."

Quick Takeaways

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A for TYRA BIOSCIENCES, INC. Common Stock, $0.0001 par value per share (TYRA).
  • Disclosed ownership: 21%.
  • Date of event: 04 Mar 2026.

What Changed

  • Previous schedule filing date: 06 Jun 2025.
  • Current filing was accepted on 06 Mar 2026, 16:28.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 21% 12,266,575 0 12,266,575 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory 0001346824
Peter Kolchinsky 21% 12,266,575 0 12,266,575 /s/ Peter Kolchinsky Peter Kolchinsky 0001384859
Rajeev Shah 21% 12,266,575 0 12,266,575 /s/ Rajeev Shah Rajeev Shah 0001619841
RA Capital Healthcare Fund, L.P. 18% 10,259,291 0 10,259,291 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager 0001315082
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .